APA (7th ed.) Citation

Specchio, N., Marsh, E., Devinsky, O., Aledo-Serrano, Á., Battaglia, D. I., Rajaraman, R., . . . Sullivan, J. (2026). Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study. Neuropediatrics, 57, S1. https://doi.org/10.1055/s-0046-1822867

Chicago Style (17th ed.) Citation

Specchio, N., et al. "Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study." Neuropediatrics 57 (2026): S1. https://doi.org/10.1055/s-0046-1822867.

MLA (9th ed.) Citation

Specchio, N., et al. "Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study." Neuropediatrics, vol. 57, 2026, p. S1, https://doi.org/10.1055/s-0046-1822867.